PL366366A1 - Klatrat hydratu azytromycyny z 1,2-propylenoglikolem, sposób jego wytwarzania i kompozycja farmaceutyczna obejmująca ten klatrat - Google Patents
Klatrat hydratu azytromycyny z 1,2-propylenoglikolem, sposób jego wytwarzania i kompozycja farmaceutyczna obejmująca ten klatratInfo
- Publication number
- PL366366A1 PL366366A1 PL02366366A PL36636602A PL366366A1 PL 366366 A1 PL366366 A1 PL 366366A1 PL 02366366 A PL02366366 A PL 02366366A PL 36636602 A PL36636602 A PL 36636602A PL 366366 A1 PL366366 A1 PL 366366A1
- Authority
- PL
- Poland
- Prior art keywords
- propyleneglycol
- clathrate
- manufacture
- pharmaceutical composition
- same
- Prior art date
Links
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 title abstract 4
- 229960004099 azithromycin Drugs 0.000 title abstract 3
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229960004063 propylene glycol Drugs 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000013078 crystal Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2001-0022406A KR100431431B1 (ko) | 2001-04-25 | 2001-04-25 | 아지트로마이신 수화물의 1,2-프로필렌글리콜 내포화합물,그의 제조방법 및 그의 약학적 조성물 |
| PCT/KR2002/000761 WO2002085898A1 (en) | 2001-04-25 | 2002-04-25 | Clathrate of azithromycin hydrate with 1,2-propyleneglycol, method for the manufacture thereof and pharmaceutical composition comprising same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL366366A1 true PL366366A1 (pl) | 2005-01-24 |
Family
ID=36578911
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL02366366A PL366366A1 (pl) | 2001-04-25 | 2002-04-25 | Klatrat hydratu azytromycyny z 1,2-propylenoglikolem, sposób jego wytwarzania i kompozycja farmaceutyczna obejmująca ten klatrat |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US7205394B2 (pl) |
| EP (1) | EP1381601B1 (pl) |
| JP (1) | JP2004528336A (pl) |
| KR (1) | KR100431431B1 (pl) |
| CN (1) | CN1226297C (pl) |
| AT (1) | ATE316086T1 (pl) |
| AU (1) | AU2002253698B2 (pl) |
| BR (1) | BR0209206A (pl) |
| CA (1) | CA2445114A1 (pl) |
| CZ (1) | CZ20033146A3 (pl) |
| DE (1) | DE60208784T2 (pl) |
| ES (1) | ES2253530T3 (pl) |
| HU (1) | HUP0303975A3 (pl) |
| IL (1) | IL158524A0 (pl) |
| MX (1) | MXPA03009663A (pl) |
| NZ (1) | NZ529082A (pl) |
| PL (1) | PL366366A1 (pl) |
| RU (1) | RU2253654C2 (pl) |
| WO (1) | WO2002085898A1 (pl) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20020231A2 (en) | 2002-03-18 | 2003-12-31 | Pliva D D | ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A |
| KR100431431B1 (ko) * | 2001-04-25 | 2004-05-14 | 한미약품 주식회사 | 아지트로마이신 수화물의 1,2-프로필렌글리콜 내포화합물,그의 제조방법 및 그의 약학적 조성물 |
| US6861413B2 (en) | 2001-05-22 | 2005-03-01 | Pfizer Inc. | Stable non-dihydrate azithromycin oral suspensions |
| AP2003002906A0 (en) | 2001-05-22 | 2003-12-31 | Pfizer Prod Inc | Crystal forms of azithromycin |
| HRP20020614A2 (en) | 2002-07-22 | 2004-06-30 | PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. | Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a |
| EP1878432A1 (en) * | 2003-07-24 | 2008-01-16 | Pliva - Research and Development Ltd. | Single dose fast dissolving azithromycin |
| PL1648473T3 (pl) * | 2003-07-24 | 2009-07-31 | Pliva Hrvatska D O O | Pojedyncza dawka szybko rozpuszczającej się azytromycyny |
| US20060116336A1 (en) * | 2004-03-17 | 2006-06-01 | American Pharmaceutical Partners, Inc. | Lyophilized azithromycin formulation |
| US7468428B2 (en) * | 2004-03-17 | 2008-12-23 | App Pharmaceuticals, Llc | Lyophilized azithromycin formulation |
| US7683162B2 (en) | 2004-08-30 | 2010-03-23 | Taro Pharmaceutical Industries Limited | Process of preparing a crystalline azithromycin monohydrate |
| US20090318375A1 (en) * | 2005-06-08 | 2009-12-24 | Hanmi Pharm Co., Ltd | Crystalline Azithromycin L-Malate Monohydrate and Pharmaceutical Composition Containing Same |
| TW200904405A (en) | 2007-03-22 | 2009-02-01 | Bristol Myers Squibb Co | Pharmaceutical formulations containing an SGLT2 inhibitor |
| US20100158821A1 (en) * | 2008-12-22 | 2010-06-24 | Eastman Chemical Company | Antimicrobial agents, compositions and products containing the same, and methods of using the compositions and products |
| US8106111B2 (en) * | 2009-05-15 | 2012-01-31 | Eastman Chemical Company | Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions |
| CN105030704B (zh) * | 2015-06-29 | 2018-09-07 | 石药集团欧意药业有限公司 | 阿奇霉素片剂及其制备方法 |
| CN105061528B (zh) * | 2015-08-05 | 2017-10-17 | 浙江维康药业股份有限公司 | 一种阿奇霉素化合物及含有该化合物的阿奇霉素软胶囊 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP940251B1 (en) * | 1994-04-15 | 1998-12-31 | Stjepan Mutak | Process for the preparation of azithromycin dihydrochloride |
| US5958888A (en) * | 1996-07-02 | 1999-09-28 | Merial, Inc. | Water miscible macrolide solutions |
| PT102130A (pt) * | 1998-03-13 | 1999-09-30 | Hovione Sociedade Quimica S A | Processo de preparacao de dihidrato de azitromicina |
| US6239112B1 (en) * | 1998-07-09 | 2001-05-29 | Merial, Inc. | Water miscible macrolide solutions |
| CA2245398C (en) * | 1998-08-21 | 2002-01-29 | Apotex Inc. | Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof |
| ES2229804T3 (es) * | 1998-11-30 | 2005-04-16 | Teva Pharmaceutical Industries Ltd. | Etannolato de azitromicina, procedimiento para su fabricacion y composiciones farmaceuticas que lo contienen. |
| US6239113B1 (en) * | 1999-03-31 | 2001-05-29 | Insite Vision, Incorporated | Topical treatment or prevention of ocular infections |
| WO2001049697A1 (en) * | 2000-01-04 | 2001-07-12 | Teva Pharmaceutical Industries Ltd. | Preparation method of azithromycin dihydrate |
| GB0017952D0 (en) * | 2000-07-22 | 2000-09-13 | Univ Manchester | Treatment of dyskinesia |
| WO2002007736A1 (en) * | 2000-07-24 | 2002-01-31 | Cadila Pharmaceuticals Limited | The process for manufacturing of clear liquid pharmaceutical composition of azithromycin |
| KR100431431B1 (ko) * | 2001-04-25 | 2004-05-14 | 한미약품 주식회사 | 아지트로마이신 수화물의 1,2-프로필렌글리콜 내포화합물,그의 제조방법 및 그의 약학적 조성물 |
| AP2003002906A0 (en) * | 2001-05-22 | 2003-12-31 | Pfizer Prod Inc | Crystal forms of azithromycin |
-
2001
- 2001-04-25 KR KR10-2001-0022406A patent/KR100431431B1/ko not_active Expired - Fee Related
-
2002
- 2002-04-25 RU RU2003134076/04A patent/RU2253654C2/ru not_active IP Right Cessation
- 2002-04-25 AU AU2002253698A patent/AU2002253698B2/en not_active Ceased
- 2002-04-25 MX MXPA03009663A patent/MXPA03009663A/es active IP Right Grant
- 2002-04-25 ES ES02722952T patent/ES2253530T3/es not_active Expired - Lifetime
- 2002-04-25 HU HU0303975A patent/HUP0303975A3/hu unknown
- 2002-04-25 EP EP02722952A patent/EP1381601B1/en not_active Expired - Lifetime
- 2002-04-25 CN CNB028089510A patent/CN1226297C/zh not_active Expired - Fee Related
- 2002-04-25 CZ CZ20033146A patent/CZ20033146A3/cs unknown
- 2002-04-25 IL IL15852402A patent/IL158524A0/xx unknown
- 2002-04-25 US US10/476,016 patent/US7205394B2/en not_active Expired - Fee Related
- 2002-04-25 AT AT02722952T patent/ATE316086T1/de not_active IP Right Cessation
- 2002-04-25 PL PL02366366A patent/PL366366A1/pl unknown
- 2002-04-25 DE DE60208784T patent/DE60208784T2/de not_active Expired - Fee Related
- 2002-04-25 CA CA002445114A patent/CA2445114A1/en not_active Abandoned
- 2002-04-25 NZ NZ529082A patent/NZ529082A/en unknown
- 2002-04-25 BR BR0209206-9A patent/BR0209206A/pt not_active IP Right Cessation
- 2002-04-25 JP JP2002583425A patent/JP2004528336A/ja not_active Withdrawn
- 2002-04-25 WO PCT/KR2002/000761 patent/WO2002085898A1/en active IP Right Grant
-
2007
- 2007-03-02 US US11/681,245 patent/US20080076725A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN1505629A (zh) | 2004-06-16 |
| JP2004528336A (ja) | 2004-09-16 |
| HUP0303975A3 (en) | 2007-11-28 |
| KR100431431B1 (ko) | 2004-05-14 |
| EP1381601B1 (en) | 2006-01-18 |
| DE60208784D1 (de) | 2006-04-06 |
| MXPA03009663A (es) | 2004-07-08 |
| AU2002253698B2 (en) | 2005-12-08 |
| HUP0303975A2 (hu) | 2004-04-28 |
| EP1381601A1 (en) | 2004-01-21 |
| US20040132673A1 (en) | 2004-07-08 |
| IL158524A0 (en) | 2004-05-12 |
| BR0209206A (pt) | 2004-07-06 |
| CA2445114A1 (en) | 2002-10-31 |
| US7205394B2 (en) | 2007-04-17 |
| ATE316086T1 (de) | 2006-02-15 |
| US20080076725A1 (en) | 2008-03-27 |
| DE60208784T2 (de) | 2006-09-28 |
| RU2253654C2 (ru) | 2005-06-10 |
| RU2003134076A (ru) | 2005-02-27 |
| CZ20033146A3 (cs) | 2004-02-18 |
| ES2253530T3 (es) | 2006-06-01 |
| EP1381601A4 (en) | 2004-06-16 |
| KR20020082682A (ko) | 2002-10-31 |
| NZ529082A (en) | 2005-04-29 |
| WO2002085898A1 (en) | 2002-10-31 |
| CN1226297C (zh) | 2005-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL366366A1 (pl) | Klatrat hydratu azytromycyny z 1,2-propylenoglikolem, sposób jego wytwarzania i kompozycja farmaceutyczna obejmująca ten klatrat | |
| GEP20063871B (en) | Inhibitors of factor xa and other serine proteases involved in the coagulation cascade | |
| MXPA04004464A (es) | Compuestos de heteroarilo sustituido con azabiciclo para el tratamiento de enfermedades. | |
| YU74600A (sh) | Inhibitori azot (ii) oksid sintaze | |
| EP1382603A4 (en) | NITROGEN COMPOUND WITH CONDENSED RINGS HAVING A PYRAZOLYL GROUP AND AS A SUBSTITUTE, AND MEDICAL COMPOSITION COMPRISING SAME | |
| CA2407100A1 (en) | 1-aroyl-piperidinyl benzamidines | |
| SE0102315D0 (sv) | Compounds | |
| NO20050741L (no) | Ny fremgangsmate for syntesen og ny krystallinsk form av agomelatin og farmasoytiske sammensetninger inneholdende den | |
| MXPA05014082A (es) | Acidos biariloximetilarenocarboxilicos. | |
| BR0107921A (pt) | Cristalização seletiva de sódio de ácido 3-piridil-1-hidroxietilideno-1,1-bisfosfÈnico como o monohidrato ou hemipentahidrato | |
| BG104644A (en) | Novel macrolides | |
| WO2005016261A3 (en) | Aripiprazole and haloperidol pamoate salts | |
| MX9803650A (es) | Agentes antimicrobianos de benzoxazina. | |
| DE60214179D1 (de) | IMIDAZOi1,2-AöPYRIDIN-DERIVATE ZUR PROPHYLAXE UND BEHANDLUNG VON HERPES-INFEKTIONEN | |
| WO2004032909A3 (en) | Stabilized pharmaceutical composition containing basic excipients | |
| AP9801253A0 (en) | 9-Oxime erythromycin derivatives. | |
| DK1328577T3 (da) | Fremgangsmåde og sammensætninger | |
| SE0301368D0 (sv) | Chemical compounds | |
| WO2004011477A3 (en) | 6,11-4-carbon bridged ketolides | |
| ATE282610T1 (de) | Heterozyklische verbindungen mit faktor xa hemmender wirkung | |
| RS19504A (en) | Novel compounds and compositions as cathepsin inhibitors | |
| WO2003101382A3 (en) | Compounds useful in the treatment of anthrax and inhibiting lethal factor | |
| NO20040821L (no) | 3-substituerte 6,7-dihydroksytetrahydroisokinolinderivater for andvendelse som antibakterielle midler. | |
| YU38103A (sh) | Nova jedinjenja askorbinske kiseline, postupci sinteze i način njihove primene | |
| ATE274513T1 (de) | Verbindungen und verfahren zur behandlung von schmerz |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DISC | Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications) |